Table 3.
Characteristic | 1986–1995 |
1996–2006 |
||
---|---|---|---|---|
HR (95% CI) | p value | HR (95 % CI) | p value | |
Age, years | ||||
|
Reference | – | Reference | – |
|
|
0.160 |
|
0.067 |
|
|
0.742 |
|
0.082 |
|
|
0.204 |
|
0.071 |
Race | ||||
|
Reference | – | Reference | – |
|
|
<0.001 |
|
<0.001 |
Hypertension |
|
– |
|
<0.001 |
Diabetes |
|
<0.001 |
|
0.015 |
Cardiovascular disease |
|
0.197 |
|
<0.001 |
Hepatitis C virus |
|
<0.001 |
|
0.007 |
CD4 count, cells/mm3 | ||||
|
Reference | – | Reference | – |
|
|
0.031 |
|
0.890 |
|
|
0.055 |
|
0.004 |
|
|
0.007 |
|
<0.001 |
Viral load, copies/ml | ||||
|
Reference | – | Reference | – |
|
|
– |
|
0.569 |
|
|
– |
|
0.305 |
|
|
– |
|
<0.001 |
Body mass index | ||||
|
|
0.743 |
|
0.375 |
|
Reference | – | Reference | – |
|
|
0.163 |
|
0.013 |
Albumin, mg/dl | ||||
|
Reference | – | Reference | – |
|
|
0.609 |
|
0.041 |
|
|
0.451 |
|
0.018 |
|
|
0.005 |
|
<0.001 |
eGFR <60 ml/min/1.73 m2 | 15.12 (8.56–26.73) | <0.001 | 18.87 (13.07–27.22) | <0.001 |
Proteinuria |
|
<0.001 |
|
<0.001 |
Multivariate model includes factors with a p value <0.05 in univariate analysis. All factors in table 1 were evaluated as candidate predictors. All estimates are adjusted for receipt of antiretroviral therapy.